<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2022.1050396</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Host defense against the infection of <italic>Klebsiella pneumoniae</italic>: New strategy to kill the bacterium in the era of antibiotics?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Zihan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2014696"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yiyao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2014980"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lai</surname>
<given-names>Yixiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2014923"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jingyi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2014925"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yin</surname>
<given-names>Lanlan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2014939"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Xiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2014878"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Yongqin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2014883"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Xinzhi</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2015626"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Song</surname>
<given-names>Yinhong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2014718"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University</institution>, <addr-line>Yichang</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institute of Infection and Inflammation, China Three Gorges University</institution>, <addr-line>Yichang</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>College of Basic Medical Science, China Three Gorges University</institution>, <addr-line>Yichang</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Affiliated Renhe Hospital of China Three Gorges University</institution>, <addr-line>Yichang</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Mathieu Coureuil, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale (INSERM), France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Michelle Darrieux, Sao Francisco University, Brazil; Samithamby Jey Jeyaseelan, Louisiana State University, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Yinhong Song, <email xlink:href="mailto:syh728@ctgu.edu.cn">syh728@ctgu.edu.cn</email>; Xinzhi Li, <email xlink:href="mailto:lixpj@163.com">lixpj@163.com</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Bacteria and Host, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>11</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>12</volume>
<elocation-id>1050396</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>09</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>11</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Liang, Wang, Lai, Zhang, Yin, Yu, Zhou, Li and Song</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Liang, Wang, Lai, Zhang, Yin, Yu, Zhou, Li and Song</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<italic>Klebsiella pneumonia</italic>e (<italic>K. pneumoniae</italic>) is a typical gram-negative iatrogenic bacterium that often causes bacteremia, pneumonia and urinary tract infection particularly among those with low immunity. Although antibiotics is the cornerstone of anti-infections, the clinical efficacy of &#x3b2;-lactamase and carbapenems drugs has been weakened due to the emergence of drug-resistant <italic>K. pneumoniae</italic>. Recent studies have demonstrated that host defense plays a critical role in killing <italic>K. pneumoniae</italic>. Here, we summarize our current understanding of host immunity mechanisms against <italic>K. pneumoniae</italic>, including mechanical barrier, innate immune cells, cellular immunity and humoral immunity, providing a theoretical basis and the new strategy for the clinical treatment of <italic>K. pneumoniae</italic> through improving host immunity.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Klebsiella pneumoniae</italic>
</kwd>
<kwd>infection</kwd>
<kwd>immunity</kwd>
<kwd>clinical treatment</kwd>
<kwd>antibiotics</kwd>
</kwd-group>
<contract-num rid="cn001">81671397, 81871956, 8210072867</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<counts>
<fig-count count="7"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="94"/>
<page-count count="15"/>
<word-count count="7018"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>
<italic>Klebsiella pneumoniae</italic>, a common gram-negative facultative anaerobic bacterium, widely exists not only in the natural soil and water but also in human and animal respiratory tract and intestinal tract (<xref ref-type="bibr" rid="B63">Paczosa and Mecsas, 2016</xref>). According to the 20-year-Antimicrobial Surveillance Program (from 1997 to 2016), <italic>K. pneumoniae</italic> (7.7%) ranks the third place in the most common pathogens, which is the leading cause of bloodstream infection (<xref ref-type="bibr" rid="B27">Diekema et&#xa0;al., 2019</xref>). It is easy to colonize on the surface of the human gastrointestinal and respiratory mucosa and cause pneumonia, urinary tract infections (UTIs), bacteremia and liver abscess in clinic (<xref ref-type="bibr" rid="B63">Paczosa and Mecsas, 2016</xref>; <xref ref-type="bibr" rid="B21">Choby et&#xa0;al., 2020</xref>). Elders, newborns and tumor patients with low immunity are generally susceptible to <italic>Klebsiella</italic> (<xref ref-type="bibr" rid="B20">Chew et&#xa0;al., 2017</xref>).</p>
<p>
<italic>Klebsiella</italic> has several subspecies, including <italic>K. pneumoniae subsp. pneumoniae</italic>, <italic>K. ozaenae subsp. ozaenae</italic> and <italic>K. rhinoscleromatis</italic>. <italic>K. pneumoniae</italic> causes more than 95% of the common clinical cases of <italic>Klebsiella</italic> infection. <italic>K. pneumoniae</italic> strains are usually classified as classical, <italic>hypervirulent K. pneumoniae</italic> (<italic>hvKp</italic>) and multidrug resistant (MDR). Classical <italic>K. pneumoniae</italic> is composed of opportunistic strains often associated with hospital infection. Highly pathogenic strains, including <italic>hvKp</italic> are considered community-acquired bacteria that infect people of all ages, including healthy people (<xref ref-type="bibr" rid="B84">Wang et&#xa0;al., 2020</xref>). <italic>hvKp</italic> is a variant of <italic>K. pneumoniae</italic>, which is more virulent than classical <italic>K. pneumoniae</italic>. <italic>hvKp</italic> is generally resistant to the third- and fourth-generation cephalosporins and has a stronger metastatic ability. The most common metastatic sites are the eyes, lung and central nervous system, which have become the focus of clinical microbial research (<xref ref-type="bibr" rid="B63">Paczosa and Mecsas, 2016</xref>; <xref ref-type="bibr" rid="B74">Russo and Marr, 2019</xref>). Furthermore, <italic>K. pneumoniae</italic> is also known for its antibiotic-resistant genes, which can spread to other gram-negative bacteria. Indeed, many antibiotic-resistance genes commonly detected in multidrug-resistant organisms were first described in <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B35">Holt et&#xa0;al., 2015</xref>). Among the isolates of <italic>K. pneumoniae</italic> reported in the European Centre for Disease Prevention and Control, more than one-third of <italic>K. pneumoniae</italic> are resistant to one or more antimicrobial agents, including fluoroquinolones, the third-generation cephalosporins and aminoglycosides (<xref ref-type="bibr" rid="B8">Bengoechea and Sa Pessoa, 2019</xref>). The invasiveness of <italic>K. pneumoniae</italic> depends on its capsule, lipopolysaccharide (LPS), fimbriae and siderophores (<xref ref-type="bibr" rid="B72">Rodr&#xed;guez-Medina et&#xa0;al., 2019</xref>). With the prevalence of <italic>hvKp</italic> and MDR, whether human will find an effective way against <italic>K. pneumoniae</italic> remains a mystery. Here, we focus on the relevant immune mechanism against <italic>K. pneumoniae</italic> to provide new clues for the clinical treatment of <italic>K. pneumoniae</italic> infection.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Innate Immune responses to <italic>K. pneumoniae</italic>
</title>
<p>
<italic>K. pneumoniae</italic> infection can be thought of as the outcome of interactions between <italic>K. pneumoniae</italic> and the host, including innate immunity and adaptive immunity. Innate immunity is the first line against <italic>K. pneumoniae</italic> infection, involving various barriers, innate immune cells and molecules.</p>
<sec id="s2_1">
<label>2.1</label>
<title>The function of barriers</title>
<sec id="s2_1_1">
<label>2.1.1</label>
<title>Respiratory barriers</title>
<p>
<italic>K. pneumoniae</italic> is one of the most common floras causing hospital-acquired infections and lower respiratory tract infections in the intensive care units (<xref ref-type="bibr" rid="B75">Saharman et&#xa0;al., 2020</xref>). When <italic>K. pneumoniae</italic> invades host, the mechanical barrier provides the immediate protection. As the interface between the host and <italic>K. pneumoniae</italic>, the respiratory tract and its epithelial cells play an active role as a mechanical barrier. Adult microbiota activates the defense of upper respiratory tract through interleukin (IL)-17A, while <italic>K. pneumoniae</italic> could overcome this obstacle to establish colonization through encapsulation (<xref ref-type="bibr" rid="B77">Sequeira et&#xa0;al., 2020</xref>). The adhesion factors with various physiological functions are present in cell wall and other structures of <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B58">Na et&#xa0;al., 2014</xref>). The colonization of <italic>K. pneumoniae</italic> could damage small airway epithelial cells and increase the level of tumor necrosis factor (TNF)-&#x3b1; in lung, and the upregulation of TNF-&#x3b1; could significantly exacerbate epithelial cell injury (<xref ref-type="bibr" rid="B93">Xu and Xu, 2005</xref>).</p>
<p>Additionally, the mucus ciliary layer of respiratory tract can adhere to or remove the bacteria or other particles entering the respiratory tract, while changes in the thickness, properties and cilia clearance of mucus influence the dismissal of <italic>K. pneumoniae</italic> by respiratory tract. Lung infection with <italic>K. pneumoniae</italic> could lead to massive infiltration of inflammatory cells, resulting in a progressive decrease in local defenses (<xref ref-type="bibr" rid="B93">Zheng et&#xa0;al., 2014</xref>). The outer membrane protein A of <italic>Klebsiella pneumoniae</italic> (KPOmpA) affects the expression of adhesion molecules and the secretion of cytokine in bronchial epithelial cells (BECs). It has been proved that KPOmpA can bind tightly to human BEC cell line BEAS-2B and primary cultures of BECs, activating the nuclear factor kappa B (NF-&#x3ba;B) signal pathway, thus stimulating the host defense. In addition, BECs exert internalized clearance of <italic>K. pneumoniae</italic> that invades the respiratory tract (<xref ref-type="bibr" rid="B66">Pichavant et&#xa0;al., 2003</xref>).</p>
<p>Therefore, mucus and ciliated epithelial cells in the respiratory system can effectively hinder the invasion of <italic>Klebsiella</italic> and eliminate it in multiple ways. However, the infection of <italic>Klebsiella</italic> could trigger an inflammatory response in the respiratory tract, leading to the accumulation of inflammatory cells, which can disrupt the mechanical barrier of the ciliary layer of respiratory tract and disturb the host defense (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The main role of respiratory barriers against <italic>K. pneumoniae. K. pneumoniae</italic> can be eliminated by BECs and the mucus cilia layer of the respiratory tract. KPOmpA from <italic>K. pneumoniae</italic> binds tightly to BECs, thereby activating NF-&#x3ba;B signal pathway to participate in the host defense. However, <italic>K. pneumoniae</italic> and its products cause airway inflammation and weaken airway defense.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-1050396-g001.tif"/>
</fig>
</sec>
<sec id="s2_1_2">
<label>2.1.2</label>
<title>Urinary barriers</title>
<p>Catheter-associated urinary tract infections (CAUTIs) is one of the most common nosocomial infections and complications of indwelling catheters (<xref ref-type="bibr" rid="B55">Maunders et&#xa0;al., 2022</xref>). <italic>K. pneumoniae</italic> is prone to UTIs through catheters, accounting for 2-6% of hospital UTIs (<xref ref-type="bibr" rid="B50">Li et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B55">Maunders et&#xa0;al., 2022</xref>). However, the mechanical force created by the flow of urine can remove pathogens normally, which acts as an essential barrier for the colonization of bacteria. Furthermore, the pH value of urine is a critical factor in the colonization and proliferation of pathogenic bacteria in the urinary tract, and the alteration of pH value may play an important role in the treatment and prevention of <italic>Klebsiella</italic> on UTIs (<xref ref-type="bibr" rid="B92">Yang et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B85">Wasfi et&#xa0;al., 2020</xref>). Meanwhile, the bladder smooth muscle activity could significantly increase the positive rate of <italic>Klebsiella</italic> in urine, which allows for flushing <italic>Klebsiella in vivo</italic> (<xref ref-type="bibr" rid="B13">Burnett et&#xa0;al., 2021</xref>). It is known that <italic>K. pneumoniae</italic> may adhere to the host cell surface with the help of various adhesion factors such as the <italic>K. pneumoniae</italic> MrkD adhesin, colonizing the host and causing infections (<xref ref-type="bibr" rid="B38">Jagnow and Clegg, 2003</xref>; <xref ref-type="bibr" rid="B48">Li et&#xa0;al., 2009</xref>). Fortunately mechanical forces such as urine activity, bladder contraction, and the alteration of pH value in urine are capable of weakening the colonization of <italic>K. pneumoniae</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The main role of urinary barrier against <italic>K. pneumoniae</italic>. The mechanical force generated by the flow of urine removes <italic>K. pneumoniae</italic> from the urinary tract, which is also an important physical barrier to reduce bacterial colonization. Moreover, the reduction of urinary pH inhibits the proliferation of <italic>K. pneumoniae</italic> in the urinary tract.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-1050396-g002.tif"/>
</fig>
</sec>
<sec id="s2_1_3">
<label>2.1.3</label>
<title>Digestive barriers</title>
<p>Studies have shown that the main anti-<italic>Klebsiella</italic> effect of digestive system comes from gut microbiota. The gut microbiota consists of diverse bacterial communities that perform various functions and influence the host&#x2019;s overall health, including nutrient metabolism, immune system regulation and natural defense against infection (<xref ref-type="bibr" rid="B1">Al Bander et&#xa0;al., 2020</xref>). During the <italic>K. pneumoniae</italic> infection, there is a complex interaction between the host and gut microbiota.</p>
<p>Researches have shown that in the early stage of <italic>K. pneumoniae</italic> infection, the richness and composition of gut microbiota changes, especially the numbers of <italic>Lactobacillus reuteri</italic> and <italic>Bifidobacterium pseudolongum</italic> decrease significantly (<xref ref-type="bibr" rid="B87">Wu et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B86">Wolff et&#xa0;al., 2021</xref>). Among the gut microbiota, <italic>Bacteroidetes</italic> can strengthen the intestinal immune barrier through IL-36 and macrophages to prevent the colonization and transmission of <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B77">Sequeira et&#xa0;al., 2020</xref>).</p>
<p>Short-chain fatty acids (SCFA), fermentation products of intestinal flora, including acetic acid, butyric acid and propionic acid, play a pivotal role in resisting the colonization and inflammation of <italic>K. pneumoniae</italic>. Vornhagen et&#xa0;al. observed that SCFA could directly inhibit bacterial growth through intracellular acidification in a dose-dependent manner. SCFA also reduces epithelial oxygenation and stimulate the expression of antimicrobial peptides in the gut microbiota, thus weakening pathogen colonization. Further, SCFA affects intestinal homeostasis to induce gut microbiota to produce metabolites, thereby decreasing the fitness of <italic>K. pneumoniae</italic> lacking functional plasmid encoding tellurite TeO3-2-resistance (Ter) operons in the intestinal tract (<xref ref-type="bibr" rid="B83">Vornhagen et&#xa0;al., 2021</xref>). Another research also showed that the G protein-coupled receptor 43 (GPR43) combined with acetate could upregulate the activity of neutrophils and alveolar macrophages, which reduce the number of bacteria in the airway in the early stage of infection, and promote inflammation regression to reduce lung injury in the late stage of infection. These results indicate that GPR43 plays a significant role in the &#x201c;gut&#x2013;lung axis&#x201d; as a sensor of the host gut microbiota activity. Increasing SCFA will probably be a new way to promote inflammation resolution in clinical practice (<xref ref-type="bibr" rid="B31">Galv&#xe3;o et&#xa0;al., 2018</xref>). Aside from that, butyrate and tryptophan decomposition metabolites are able to enhance gut integrity and stimulate innate lymphoid cells group 3 (ILC3) to produce IL-22. Gut microbiota also could reduce intestinal permeability and increase the epithelial defense mechanism to form a mucosal barrier. Therefore, they maintain the stability of the intestinal environment (<xref ref-type="bibr" rid="B78">Shi et&#xa0;al., 2017</xref>). In the case of liver abscess induced by <italic>K. pneumoniae</italic>, relevant studies have discovered that antibiotic treatment before <italic>K. pneumoniae</italic> infection weakens the protective effect of intestinal flora in mice. Surprisingly, after fecal transplantation, the concentrations of chemokine (C-X-C motif) ligand 1 protein (CXCL1), TNF-&#x3b1;, monocyte chemoattractant protein-1 (MCP-1), IL-1&#x3b2;, IL-6 and IL-17 in mice serum were recovered and liver injury was alleviated (<xref ref-type="bibr" rid="B94">Zheng et&#xa0;al., 2021</xref>).</p>
<p>In a word, gut microbiota and its metabolites is essential in <italic>K. pneumoniae</italic> colonization and inflammatory response (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). Administration of exogenous SCFA could be sufficient to reduce fitness of <italic>K. pneumoniae</italic>. However, whether other substances also have impacts and how these microorganisms and metabolites interact with the host remains need to be further explored.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>The main role of digestive barrier against <italic>K. pneumoniae</italic>. The gut microbiota and their metabolites can reduce the colonization and transmission of <italic>K. pneumoniae</italic> and inhibit inflammation by regulating the activity of immune cells and inflammatory factors.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-1050396-g003.tif"/>
</fig>
</sec>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>The function of innate immune cells</title>
<sec id="s2_2_1">
<label>2.2.1</label>
<title>Dendritic cells</title>
<p>Dendritic cells (DCs) of the lung are situated in close proximity to alveolar epithelium and resident alveolar macrophages, playing a specific role as antigen-presenting cells (APCs) (<xref ref-type="bibr" rid="B82">Von Wulffen et&#xa0;al., 2007</xref>). There are several subtypes of DCs. Plasmacytoid DCs (pDCs) can produce interferon (IFN)-&#x3b1; and sense the damaged skin to heal wounds. CD103<sup>+</sup> DCs, CD11b<sup>hi</sup> DCs and monocyte-derived DCs (MoDCs) can act as migratory DCs to promote the activation of na&#xef;ve CD4<sup>+</sup> and CD8<sup>+</sup> T cells in lymph nodes (<xref ref-type="bibr" rid="B34">Hackstein et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B67">Plantinga et&#xa0;al., 2013</xref>). Hackstein et&#xa0;al. discovered a rapid increase of activated CD103<sup>+</sup> DC, CD11b<sup>+</sup> DC and MoDC within 48&#xa0;h post infection of <italic>K. pneumoniae.</italic> The <italic>K. pneumoniae</italic>-infected animals showed that in respiratory DC subpopulations there were elevated IFN-&#x3b1; in pDC, elevated IFN-&#x3b3;, IL-4 and IL-13 in CD103<sup>+</sup> DC and IL-19 and IL-12p35 in CD11b<sup>+</sup> DC subsets in comparison to CD11c<sup>+</sup> MHC-class II<sup>low</sup> cells indicating distinct functional roles. CD103<sup>+</sup> DC and CD11b<sup>+</sup> DC subsets represented the most potent na&#xef;ve CD4<sup>+</sup> T helper cell activators in the infection model of <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B33">Hackstein et&#xa0;al., 2013</xref>) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). Therefore, the novel insight into the activation of respiratory DC subsets during <italic>K. pneumonia</italic> infection is provided.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>The main role of innate immune cells against <italic>K. pneumoniae</italic>. Neutrophils produce NETs to eliminate <italic>K. pneumoniae</italic> directly. Meanwhile, CD103<sup>+</sup>DCs, CD11b<sup>hi</sup> and MODCs promote the activation of na&#xef;ve T cells. CCR2 and HIF-1a activate macrophages to secrete cytokines such as TNF-&#x3b1;, IL-6 and IL-36&#x3b3; to eradicate the bacterium.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-1050396-g004.tif"/>
</fig>
</sec>
<sec id="s2_2_2">
<label>2.2.2</label>
<title>Macrophages</title>
<p>Pulmonary macrophages are derived from monocytes, which mainly stimulate other immune cells acting as APCs and secreting immune molecules. The latest experiments showed that capsular polysaccharide (CPS) derived from carbapenem-resistant <italic>K. pneumoniae KN2</italic> serotype can stimulate J774A.1 mouse macrophage to release TNF-&#x3b1; and IL-6 <italic>in vitro</italic>. The CPS also exerts an immune response through TLR4 in human embryonic kidney-293 (HEK-293) cells (<xref ref-type="bibr" rid="B46">Lee et&#xa0;al., 2022</xref>). Melissa and Kovach observed that the clearance rate of <italic>K. pneumoniae</italic> in IL-36&#x3b3;-deficient mice was decreased and the mortality of the mouse was increased, which confirmed that IL-36&#x3b3; is related to the anti-<italic>Klebsiella</italic> effect. Further, it is proved that pulmonary macrophages secreted IL-36&#x3b3; in a non-Golgi-dependent manner, playing a critical role in innate mucosal immunity of lung (<xref ref-type="bibr" rid="B44">Kovach et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B43">Kovach et&#xa0;al., 2017</xref>). The chemokine-mediated transportation of mononuclear phagocytes also is essential in the defense against bacterial pneumonia. In the <italic>K. pneumoniae</italic>-infected mouse model, the deletion of chemotactic cytokines receptor 2 (CCR2) could reduce all the monocyte phagocyte subsets and change the phenotype of pulmonary macrophages, reducing the amount of M1 macrophages and TNF in lung (<xref ref-type="bibr" rid="B19">Chen et&#xa0;al., 2013</xref>). Myeloid but not neutrophil-specific hypoxia-inducible factor (HIF)-1&#x3b1;-deficient mice increased bacterial loads in the lungs and distant organs after infection of <italic>K. pneumoniae</italic> as compared to control mice, pointing to a role of HIF-1&#x3b1; in macrophages. What&#x2019;s more, alveolar and lung interstitial macrophages from myeloid-specific HIF-1&#x3b1;-deficient mice produced a lower level of immunity, suggesting the importance of HIF-1&#x3b1; expressed in lung macrophages in protective innate immunity during pneumonia caused by <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B62">Otto et&#xa0;al., 2021</xref>).</p>
<p>Collectively, the researches above indicate that pulmonary macrophage is essential in innate immunity by secreting cytokine such as IL-36, TNF-&#x3b1; and IL-6 after <italic>K. pneumoniae</italic> infection, while CCR2 and HIF-1&#x3b1; play an auxiliary role in the anti-<italic>K. pneumoniae</italic> activity of macrophages (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). These discoveries provide new ideas for the clinical treatment of pneumonia caused by <italic>Klebsiella</italic> infection.</p>
</sec>
<sec id="s2_2_3">
<label>2.2.3</label>
<title>Neutrophils</title>
<p>Neutrophils are the first line against a variety of infectious pathogens. Neutrophils could kill pathogens by phagocytosis and neutrophil extracellular traps (NETs). NETs is one of the primary defensive mechanisms of neutrophils against <italic>carbapenemase resistant hypervirulent K. pneumoniae</italic> (<italic>CR-hvKp</italic>). Through the scanning electron microscope test, Jin et&#xa0;al. found that the NETs in type 2 diabetes patients had lost its smooth and regular shape, which may lead to the defection of congenital immune response for the patients against <italic>CR-hvKp</italic>. The study confirmed the direct killing effect of NETs to <italic>CR-hvKp</italic> (<xref ref-type="bibr" rid="B41">Jin et&#xa0;al., 2020</xref>). More recently researchers compared the concentration of cytokines in regular diet group of mice and high-fat diet group infected with <italic>K. pneumoniae</italic>, discovering that the concentrations of IL-1&#x3b2;, IL-6, IL-17, IFN- &#x3b3;, CXCL2 and TNF-&#x3b1; were much lower in the high-fat diet group, meanwhile, the number of neutrophils was reduced, and the functions including the phagocytosis, killing ability and production of the reactive oxygen intermediates (ROI) were impaired significantly, which proved the critical role of neutrophils in anti-<italic>K. pneumoniae</italic> effect (<xref ref-type="bibr" rid="B53">Mancuso et&#xa0;al., 2022</xref>).</p>
<p>Further studies found that the expression of CXCL5 in IL-17-deficient epithelium decreased, while intranasal injection of recombinant CXCL5 in mice could restore neutrophils&#x2019; recruitment and bacterial clearance (<xref ref-type="bibr" rid="B18">Chen et&#xa0;al., 2016</xref>). It was also discovered that the number of neutrophils decreased and the production of leukotriene B<sub>4</sub> (LTB<sub>4</sub>), reactive oxygen species (ROS) and reactive nitrogen species (RNS) decreased in CXCL1-/- mice infected with <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B7">Batra et&#xa0;al., 2012</xref>). Meanwhile, subsequent experiments on depleted neutrophils showed that neutrophils were the main source of LTB<sub>4</sub> in the lungs after infection (<xref ref-type="bibr" rid="B7">Batra et&#xa0;al., 2012</xref>). The above researches reveal the important role of CXCL1 in the expression of ROS and RNS produced by neutrophils, the regulation of host immunity to <italic>K. pneumoniae</italic> infection, and the curative effect of LTB<sub>4</sub> on the recruitment of neutrophils. In addition, more studies have shown that IL-33 can enhance host defense during bacterial pneumonia through the combined function of neutrophils and inflammatory monocytes (<xref ref-type="bibr" rid="B69">Ramirez-Moral et&#xa0;al., 2021</xref>).</p>
<p>Evidences <italic>in vitro</italic> and <italic>in vivo</italic> above indicate that neutrophils play an anti-<italic>K. pneumonia&#x2019;s</italic> role mainly through NETs and secreting corresponding molecules such as LTB<sub>4</sub>, ROS and RNS (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). What&#x2019;s more, the administration of CXCL5 and LTB<sub>4</sub> can restore the activity of neutrophils, providing a new direction for the clinical treatment of <italic>K. pneumoniae</italic>.</p>
</sec>
<sec id="s2_2_4">
<label>2.2.4</label>
<title>Innate Lymphoid Cells</title>
<p>All T lymphocytes including T<sub>H</sub>17 and &#x3b3;&#x3b4;T subsets participating in innate immunity derive from common lymphoid progenitor in bone marrow, differentiate and mature in thymus. &#x3b3;&#x3b4;17 cell is a subset of &#x3b3;&#x3b4;T cells which produce large quantities of IL-17A in the presence of IL-23 and IL-1&#x3b2;. &#x3b3;&#x3b4;17 cell expresses the type I IL-4R. And IL-4 signaling increases STAT6 phosphorylation in &#x3b3;&#x3b4;T cells. Whereas IL-4 inhibits the production of IL-17A by &#x3b3;&#x3b4;17 cell. <italic>K. pneumoniae</italic> infection of STAT6 knockout mice shows a higher amount of &#x3b3;&#x3b4;17 cell compared to that of wild-type mice, demonstrating that STAT6 signaling negatively regulates &#x3b3;&#x3b4;17 cell that play a front-line role in mucosal immunity against <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B11">Bloodworth et&#xa0;al., 2016</xref>). Recently, Mackel et&#xa0;al. evaluated the role of T cells in protection against classical <italic>K. pneumoniae</italic> reinfection and demonstrated that mice lacking T cells were unable to establish a protective response. However, mice individually deficient in either of the major T cell subsets, &#x3b3;&#x3b4; or &#x3b1;&#x3b2; (classical T cells), effectively mounted a protective response, indicating either subset alone was sufficient to mediate protection against the reinfection of <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B51">Mackel et&#xa0;al., 2022</xref>) (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). The researches above demonstrate the imperative contribution of innate T cells to protective immunity against classical <italic>K. pneumoniae</italic> and will guide further inquiries into host effector responses required to control <italic>K. pneumoniae</italic> infection.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>The main role of innate lymphoid cells against <italic>K. pneumoniae</italic>. NK cells and its subsets mainly eliminate <italic>K. pneumoniae</italic> indirectly by producing cytokines. &#x3b3;&#x3b4;17 cells facilitate the eradication of <italic>K. pneumoniae</italic> by secreting IL17A, which can be suppressed by high level of IL-4.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-1050396-g005.tif"/>
</fig>
<p>Nature killer (NK) cells, which belong to innate lymphoid cells (ILCs), are found to recognize and eliminate &#x201c;altered self&#x201d; as cytotoxic lymphocytes, which also take part as the source of early inflammatory cytokines in the innate immune system (<xref ref-type="bibr" rid="B64">Pallmer and Oxenius, 2016</xref>; <xref ref-type="bibr" rid="B57">Myers and Miller, 2021</xref>). After activation, they secrete perforin and TNF to kill &#x201c;allosome&#x201d; substances nonspecifically. It was found that after infection with <italic>K. pneumoniae</italic>, the survival rate of IL-22<sup>-/-</sup> mouse was lowered while the survival rate of Rag2<sup>-/-</sup> mouse had no significant changes compared with wild-type mouse. Simultaneously, Rag2<sup>-/-</sup>Il2rg<sup>-/-</sup> mice failed to produce IL-22. NK cells and T cells may produce IL-22 and have conventional host defense against <italic>K. pneumoniae</italic>, which were confirmed with Rag2<sup>-/-</sup>Il2rg<sup>-/-</sup> C57BL/6 mice (<xref ref-type="bibr" rid="B90">Xu et&#xa0;al., 2014</xref>). Type I IFN receptor (<italic>Ifnar</italic>) 1-deficient mice infected with <italic>K. pneumoniae</italic> failed to activate NK cells to produce IFN-&#x3b3;, which caused the weakening of NK cell killing effect. Meanwhile, exogenous IFN-&#x3b3; can recover the level of IFN-&#x3b3; in <italic>Ifnar1</italic>
<sup>fl/fl</sup> (Ifnar1<sup>tm1Uka</sup>)-CD11c<sup>Cre</sup>, <italic>Ifnar1</italic>
<sup>fl/fl</sup>-LysM<sup>Cre</sup> and <italic>Ifnar1</italic>
<sup>fl/fl</sup>-MRP8<sup>Cre</sup> mice on C57BL/6 background (<xref ref-type="bibr" rid="B36">Ivin et&#xa0;al., 2017</xref>). These data identify NK cell-intrinsic type I IFN signaling as essential driver of <italic>K. pneumoniae</italic> clearance, and reveal a specific target for future therapeutic exploitations (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>).</p>
</sec>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>The function of innate immune molecules</title>
<sec id="s2_3_1">
<title>2.3.1 TLRs</title>
<p>Innate immunity depends on signals produced by pattern recognition receptors (PRRs). Toll-like receptors (TLRs) is the earliest PRRs, which can recognize pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) in microorganisms (<xref ref-type="bibr" rid="B59">O&#x2019;neill et&#xa0;al., 2013</xref>). When the ligand binds to TLRs, myeloid differentiation factor88 (MyD88) and Toll/IL-1R (TIR) domain-containing adaptor protein (TIRAP) are recruited into the TLR complex to activate MAPK and NF-&#x3ba;B signal pathways to produce cytokines and chemokines. This cascade reaction is called MyD88-dependent pathway. In the lung against <italic>K. pneumoniae</italic> TIRAP is a critical mediator of antibacterial defense (<xref ref-type="bibr" rid="B40">Jeyaseelan et&#xa0;al., 2006</xref>). Besides, the activation of TLRs also recruits other adapter proteins, such as TIR domain-containing adaptor-inducing IFN-&#x3b2; (TRIF) and TRIF-related adaptor molecule (TRAM). This pathway activates NF-&#x3ba;B and type I IFN, which is called TRIF-dependent pathway. Both TRIF-dependent and MyD88-dependent signaling contributes to host defense against pulmonary <italic>Klebsiella</italic> infection (<xref ref-type="bibr" rid="B15">Cai et&#xa0;al., 2009</xref>). The TLR-mediated innate immune responses control bacterial growth at the infection site, thus minimizing bacterial transmission. Currently, 12 TLRs from mice and 10 TLRs from human have been identified (<xref ref-type="bibr" rid="B6">Baral et&#xa0;al., 2014</xref>).</p>
<p>Among TLRs, TLR2 and TLR4 play important roles in <italic>K. pneumoniae</italic> infection. TLR2 transmits signal mainly by forming heterodimers with TLR1 or TLR6 to resist external pathogens. Meanwhile, TLR4 could induce host defense against gram-negative bacterial pulmonary infection by sensing bacterial LPS (<xref ref-type="bibr" rid="B6">Baral et&#xa0;al., 2014</xref>). Compared with wild type (WT) mice, Jeon et&#xa0;al. found that the survival time of TLR4 knock-out (KO) and TLR2/4 double KO (DKO) mice infected with 5&#xd7;10<sup>3</sup> CFU <italic>K. pneumoniae</italic> was significantly shortened. The mRNA levels of TNF-&#x3b1;, MCP-1 and inducible nitric oxide synthase (iNOS) in TLR2/4 DKO mice were substantially lower than those in the WT group, indicating that TLR2 and TLR4 play a synergistic role in innate immune response during <italic>K. pneumoniae</italic> infection (<xref ref-type="bibr" rid="B39">Jeon et&#xa0;al., 2017</xref>).</p>
<p>Meanwhile, by analyzing the gene expression profiles in the lung of C57BL/6 mice (resistant to bacterial transmission), 129/SVJ mice (susceptible), C3H/HeJ mice (susceptible and TLR4 signal deficient) and their respective control strains C3H/HeN mice (moderately resistant), it was found that the most significant number of TLR4-dependent induced genes were expressed in C57BL/6 and C3H/HeN mice after infection with <italic>K. pneumoniae</italic>. These genes include cytokines and chemokine genes needed for neutrophil activation or recruitment, growth factor receptors, MyD88 and adhesion molecules. The results indicated that in the early stage of infection, the TLR4 signal controlled the expression of most genes in lung to cope with gram-negative bacterial infection (<xref ref-type="bibr" rid="B76">Schurr et&#xa0;al., 2005</xref>).</p>
<p>At the same time a variety of TLRs expressed on DCs, such as TLR9, can trigger the cascade signal response of proinflammatory cytokines, leading to the production of TNF-&#x3b1;, IL-12 and other proinflammatory cytokines in large quantities to resist the invasion of <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B10">Bhan et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B82">Von Wulffen et&#xa0;al., 2007</xref>). Interestingly, though the initiation of most TLRs depends on MyD88, Adam et&#xa0;al. discovered that the inflammatory response induced by <italic>K. pneumoniae</italic> does not depend on MyD88 in lung epithelial cells and platelets (<xref ref-type="bibr" rid="B24">De Stoppelaar et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B4">Anas et&#xa0;al., 2017</xref>).</p>
<p>Collectively, TLR2 and TLR4 signaling could improve the levels of TNF-&#x3b1;, MCP-1, iNOS and other proinflammatory cytokines to indirectly eliminate the bacteria during the early stage of <italic>K. pneumoniae</italic> infection (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>The main role of immune molecules against <italic>K. pneumoniae</italic>. pDCs secrete NLRP12 participating NF-&#x43a;B and MAPK signal pathways to regulate the inflammation caused by <italic>K. pneumoniae</italic>. While TLR2, TLR4 and TLR9 promote the production of TNF-&#x3b1; and IL-12. Macrophage-derived NLRC4 induces the production of IL-1 and IL-17A in lung, activating NF-&#x3ba;B and MAPK signal pathways to upregulate the production of chemokine, TNF-&#x3b1;, ICAM-1 and VCAM-1, which can recruit neutrophils. Meanwhile, NLRP12-IL-17A-CXCL1 axis, CCL2 and CCL7 recruit neutrophils, &#x3b3;&#x3b4;T cells and NK cells to eliminate <italic>K. pneumoniae</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-1050396-g006.tif"/>
</fig>
</sec>
<sec id="s2_3_2">
<label>2.3.2</label>
<title>NLRs</title>
<p>Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are classical pattern recognition receptors highly expressed in first-reactive cells such as neutrophils, macrophages and DC cells. They can regulate various signal pathways, including MyD88 and TLRs containing adaptor molecular 1-dependent pathways. Besides these regulatory effects, some NLRs also are assembled into polymer protein complexes called inflammasome (<xref ref-type="bibr" rid="B70">Ravi Kumar et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B32">Ghimire et&#xa0;al., 2020</xref>).</p>
<p>Nucleotide-binding oligomerization domain, leucine- rich repeat and pyrin domain-containing (NLRP) is one category of NLRs. Studies have shown that NLRP6 and NLRP12 can act as a negative regulator of the NF-&#x3ba;B and mitogen-activated protein kinase (MAPK) signal pathways to attenuate intestinal inflammation during the infection of <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B32">Ghimire et&#xa0;al., 2020</xref>). NLRP6 and the adaptor protein, apoptosis-associated speck-like protein (ASC) -mediated inflammasome activation are thought to shape the composition of the commensal gut microbiota, controlling the gut microbiota and the immune response to systemic and intestinal infections (<xref ref-type="bibr" rid="B28">Elinav et&#xa0;al., 2011</xref>). However, the finding was challenged by later research (<xref ref-type="bibr" rid="B52">Mamantopoulos et&#xa0;al., 2017</xref>). It is meaningful that during the infection of <italic>K. pneumoniae</italic>, <italic>NLRP6</italic> gene-deficient mice show the low levels of neutrophil recruitment, CXC chemokine and granulocyte factor (<xref ref-type="bibr" rid="B17">Cai et&#xa0;al., 2021</xref>).</p>
<p>Furthermore, bone marrow-derived DCs (BMDCs) lacking NLRP12 could induce the production of TNF-&#x3b1; and IL-6 (<xref ref-type="bibr" rid="B2">Allen et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B80">Tuladhar and Kanneganti, 2020</xref>). It was found that intratracheal injection of IL-17A<sup>+</sup> CD4 T cells or CXCL1<sup>+</sup> macrophages could prolong the survival of <italic>Nlrp12</italic>
<sup>-/-</sup> mice and recruit neutrophils to eliminate <italic>K. pneumoniae</italic>. It was revealed that the NLRP12-IL-17A-CXCL1 axis <italic>in vivo</italic> could play a vital role in removing extracellular bacteria by recruiting neutrophils (<xref ref-type="bibr" rid="B14">Cai et&#xa0;al., 2016</xref>). And another study found that IL-17 can upregulate the expression of CCR2 ligands CCL2 and CCL7, promoting the recruitment of neutrophils and enhancing the anti-bacterial activity in C57BL/6 mice (<xref ref-type="bibr" rid="B88">Xiong et&#xa0;al., 2015</xref>).</p>
<p>NLRC4, another inflammasome, is also essential for the clearance of <italic>K. pneumoniae</italic> and neutrophil-mediated lung inflammation (<xref ref-type="bibr" rid="B88">Xiong et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B89">Xiong et&#xa0;al., 2016</xref>). Macrophage-derived NLRC4 can induce the production of IL-1 and IL-17A from NK cells and &#x3b3;&#x3b4;T cells in lung, activating NF-&#x3ba;B and MAPK signal pathways to regulate the production of neutrophil chemokine, TNF-&#x3b1;, the expression of intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in lung homogenates, which could recruit neutrophils and hinder the colonization of <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B16">Cai et&#xa0;al., 2012</xref>).</p>
<p>These evidences revealed that NLRP6 and NLRP12 could act as negative regulators of NF-&#x3ba;B and MAPK signal pathways to deregulate the inflammation caused by <italic>K. pneumoniae.</italic> Meanwhile, NLRs prevent the colonization of <italic>K. pneumoniae</italic> by recruiting neutrophils (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>).</p>
</sec>
</sec>
</sec>
<sec id="s3">
<label>3</label>
<title>Adaptive Immune Response to <italic>K. pneumoniae</italic>
</title>
<p>It is known that innate immunity and adaptive immunity are equally crucial in resisting pathogen invasion, the adaptive immune response is slower and more specific. Another prominent feature for adaptive immunity is the production of immunologic memory which is activated rapidly during reinfection, resulting in protective response (<xref ref-type="bibr" rid="B12">Bonilla and Oettgen, 2010</xref>; <xref ref-type="bibr" rid="B61">Opoku-Temeng et&#xa0;al., 2022</xref>). Adaptive immunity includes T cell-mediated cellular response and B cell-mediated humoral response (<xref ref-type="bibr" rid="B12">Bonilla and Oettgen, 2010</xref>).</p>
<sec id="s3_1">
<label>3.1</label>
<title>T Cell-mediated Immune Response</title>
<p>As <italic>K. pneumoniae</italic> is a typical extracellular bacterium, the effect of cellular immunity on <italic>K. pneumoniae</italic> is relatively limited (<xref ref-type="bibr" rid="B61">Opoku-Temeng et&#xa0;al., 2022</xref>). Lee et&#xa0;al. found that T-helper (T<sub>H</sub>) lymphocytes played a prominent role in the defense of <italic>K. pneumoniae</italic> through secreting cytokines such as IL-17 and IFN-&#x3b3; (<xref ref-type="bibr" rid="B45">Lee et&#xa0;al., 2015</xref>). It was found that resident memory T cells (T<sub>RM</sub>) also played an anti-<italic>Klebsiella</italic> role through lung mucosal immunity. Vesely et&#xa0;al. discovered that the lung long-lived CD4 T<sub>RM</sub> cells derived from T<sub>H</sub>17 cells could rapidly release IFN-&#x3b3; or release IL-4 later to better control infections of CR-hvKp or contribute to the pathology associated with the hypersensitivity (<xref ref-type="bibr" rid="B3">Amezcua Vesely et&#xa0;al., 2019</xref>). Meanwhile, the newly studied vaccine can drive lung T<sub>RM</sub> cells to provide immunity against <italic>Klebsiella via</italic> fibroblast IL-17R signaling (<xref ref-type="bibr" rid="B37">Iwanaga et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Humoral Immune Response</title>
<p>It is different from cellular immunity, humoral immunity exerts an enormous function in host defense against <italic>K. pneumoniae</italic> infection. Banerjee et&#xa0;al. had isolated cross-reactive anti-CPS antibodies poly-immunoglobulin G (poly-IgG) from the plasma of patients infected with <italic>carbapenem-resistant K. pneumoniae</italic> (<italic>CR-Kp</italic>) strain sequence type 258 (ST258), which indicated poly-IgG could promote the phagocytic function to different serotype <italic>CR-Kp</italic> strains. Still, the protective efficacy was reversed when CPS-specific antibodies (Abs) were depleted (<xref ref-type="bibr" rid="B5">Banerjee et&#xa0;al., 2021</xref>). Diago et&#xa0;al. isolated K1-CPS-specific IgG Abs and found that in mouse liver, monoclonal antibodies (mAbs) 4C5 and 19A10 reduced the transmission of <italic>CR-hvKp</italic> with <italic>in vivo</italic> microscope (<xref ref-type="bibr" rid="B25">Diago-Navarro et&#xa0;al., 2017</xref>). Subsequently, two anti-CPS IgG mAbs 17H12 and 8F12 were obtained by Diago et&#xa0;al. from the mouse infection model. The two mAbs can promote extracellular processes to kill <italic>CR-Kp</italic>, including the enhancement of biofilm inhibition, the deposition of complement and NETs, reducing bacterial transmission to organs (<xref ref-type="bibr" rid="B26">Diago-Navarro et&#xa0;al., 2018</xref>). Motley and his fellows also isolated two anti-CPS mAbs, murine IgG3 (mIgG3) and murine IgG1 (mIgG1), revealing that mIgG3 had better complement-mediated serum bactericidal activity than mIgG1, and promoting neutrophil-mediated killing at a concentration below mIgG1 through enzyme-linked immunosorbent assay and flow cytometry. In contrast, mIgG1 had better activity in enhancing the phagocytosis of macrophages (<xref ref-type="bibr" rid="B56">Motley et&#xa0;al., 2020</xref>).</p>
<p>Kobayashi et&#xa0;al. tested CPS-specific rabbit Abs and found that CPS2-specific Abs can promote phagocytosis and the pernicious effect of human neutrophils to ST258 (<xref ref-type="bibr" rid="B42">Kobayashi et&#xa0;al., 2018</xref>). Observing the interaction of African green monkey complement and antibodies with hyper mucoviscosity (HMV) or non-HMV <italic>K. pneumoniae</italic>, the results demonstrate that interaction of cellular and humoral immune elements plays a role in the <italic>in vitro</italic> killing of <italic>K. pneumoniae</italic>, particularly HMV isolates. However, low levels of IgG2 titers may lead to a diminished sterilization effect (<xref ref-type="bibr" rid="B79">Soto et&#xa0;al., 2016</xref>). The increased prevalence of <italic>K. pneumoniae</italic> LPS O2 serotype strains in all significant drug resistance groups correlates with a paucity of anti-O2 antibodies in human B cell repertoires. It has been identified that human mAbs to O antigen, including a rare anti-O2 specific antibody, is highly protective in mouse infection models, even against heavily encapsulated strains (<xref ref-type="bibr" rid="B65">Pennini et&#xa0;al., 2017</xref>).</p>
<p>Furthermore, an isolated antibody B39 targeting conserved epitope binds to <italic>K. pneumoniae</italic> LPS O1 and O1/O2 antigens could promote the conditioning phagocytosis of human macrophages and the clearance of macrophage-associated bacteria when evaluating them by high-volume image (<xref ref-type="bibr" rid="B9">Berry et&#xa0;al., 2022</xref>). At the same time, Lee. et&#xa0;al. found that <italic>K. pneumoniae</italic> EV vaccination conferred protection against <italic>K. pneumoniae</italic> infection by inducing EV-reactive Abs and IFN-&#x3b3;<sup>+</sup> T-cell responses. It indicates that <italic>K. pneumoniae</italic> EV vaccination depends on both humoral and cellular immunity (<xref ref-type="bibr" rid="B45">Lee et&#xa0;al., 2015</xref>). Similarly, stable artificial bacterial bionic vesicles (BBVs) were successfully induced and efficiently taken up by DCs to stimulate DCs&#x2019; maturation. Therefore, as a <italic>K. pneumoniae</italic> vaccine, BBVs could induce bacterial-specific humoral and cellular immune responses to reduce lung inflammation and its bacterial load (<xref ref-type="bibr" rid="B49">Li et&#xa0;al., 2021</xref>).</p>
<p>Collectively, these studies strongly suggest the critical role of humoral immunity, which is underestimated in clinical applications in terms of antibiotic therapy. Due to the protective potential of anti-CPS, <italic>K. pneumoniae</italic> CPS is a popular target for immune prevention and/or treatment, and the O antigen of LPS and EVs are also viable targets (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>). In addition, antibody-based clinical treatment strategies may have the capacity to address antibiotic-refractory bacteria in the future.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>The main role of humoral immune response against <italic>K. pneumoniae</italic>. Multiple antibodies can act on different antigenic epitopes of <italic>K. pneumoniae</italic>, including vesicles, O-antigen on LPS, and antigen on CPS.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-1050396-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion and conclusion</title>
<p>Over the past decade, <italic>K. pneumoniae</italic> has emerged as a significant clinical and public health threat due to the increasing prevalence of healthcare-associated infections caused by multidrug-resistant strains that produce extended-spectrum &#x3b2;-lactamases and/or carbapenemases. Here, the immune mechanisms associated with the resistance to <italic>K. pneumoniae</italic>, including innate immunity, cellular immunity and humoral immunity have been reviewed (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). The mechanical barriers play a preliminary role in anti-colonization, while humoral immunity antibodies can recognize different antigenic epitopes of <italic>K. pneumoniae</italic> to promote the elimination of the pathogen. At the same time, multiple immune cells are activated and able to secrete relevant immune factors to aggregate and destroy the infected cells when the organism is infected with <italic>Klebsiella</italic>, demonstrating the diversity and effectiveness of immunity. On the other hand, the immune evasion and pathogenicity of <italic>K. pneumoniae</italic> also reflect the vital role of immunity against <italic>K. pneumoniae</italic>. The current treatments of <italic>hvKp</italic> infection are controlling infection source and aggressive antibiotic therapy. However, due to the diminished effectiveness of conventional clinical treatment against antibiotic-resistant and highly pathogenic strains (<xref ref-type="bibr" rid="B21">Choby et&#xa0;al., 2020</xref>b), improving individuals&#x2019; immunity against <italic>K. pneumoniae</italic> infection may become a new direction for clinical therapy in the future. For the aim above, some measures, for example, regulating the gut microbiota, increasing SCFA, supplying specific antibody and so on, should be taken.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Studies on the mechanism of host defense against <italic>K. pneumoniae (Kp)</italic> infection.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" colspan="2" align="center">Mechanism of host defense against <italic>Kp</italic>
</th>
<th valign="top" align="center">Reference</th>
</tr>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" align="center">Mechanism</th>
<th valign="top" align="center">Influence</th>
<th valign="top" align="center"/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="30" align="left">Innate immune response</td>
<td valign="top" rowspan="10" align="left">Barriers</td>
<td valign="top" rowspan="2" align="left">respiratory barriers</td>
<td valign="top" align="center">respiratory epithelial cells</td>
<td valign="top" align="center">Internalize and eliminate</td>
<td valign="top" align="center">(Xu and Xu, 2005)</td>
</tr>
<tr>
<td valign="top" align="center">IL-17A</td>
<td valign="top" align="center">Activate the defense of upper respiratory tract</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B77">Sequeira et&#xa0;al., 2020</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="3" align="left">urinary barriers</td>
<td valign="top" align="center">Mechanical force of urine flow</td>
<td valign="top" align="center">Prevent the colonization of <italic>Kp</italic> on urethra</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B55">Maunders et&#xa0;al., 2022</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Urine pH&#x2193;</td>
<td valign="top" align="center">Affect the colonization and proliferation of bacteria</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B92">Yang et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B85">Wasfi et&#xa0;al., 2020</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Mechanical force of bladder contraction</td>
<td valign="top" align="center">Conducive to <italic>Kp</italic> removal</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B13">Burnett et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="5" align="left">digestive barriers</td>
<td valign="top" align="center">IL-36, macrophages</td>
<td valign="top" align="center">Prevent the colonization and transmission of bacteria</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B77">Sequeira et&#xa0;al., 2020</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">SCFA</td>
<td valign="top" align="center">Prevent the growth and colonization of bacteria</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B83">Vornhagen et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Combined SCFA with GPR43</td>
<td valign="top" align="center">Reduce the number of <italic>Kp</italic> and control the inflammatory response</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B31">Galv&#xe3;o et&#xa0;al., 2018</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Mucosal barrier</td>
<td valign="top" align="center">Inhibit inflammation</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B78">Shi et&#xa0;al., 2017</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Intestinal flora</td>
<td valign="top" align="center">Reduce liver injury</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B94">Zheng et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="10" align="left">Innate immune cells</td>
<td valign="top" align="left">dendritic cells</td>
<td valign="top" align="center">pDCs, CD103<sup>+</sup>DC, MoDCs&#x2191;</td>
<td valign="top" align="center">Stimulate CD4<sup>+</sup> and CD8<sup>+</sup> na&#xef;ve T cells</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B33">Hackstein et&#xa0;al., 2013</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="4" align="left">macrophages</td>
<td valign="top" align="center">Release TNF-&#x3b1; and IL-6</td>
<td valign="top" align="center">Promote inflammation</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B46">Lee et&#xa0;al., 2022</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">IL-36&#x3b3;</td>
<td valign="top" align="center">Promote innate mucosal immunity in lung</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B44">Kovach et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B43">Kovach et&#xa0;al., 2017</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">CCR2</td>
<td valign="top" align="center">Increase macrophages and TNF</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B19">Chen et&#xa0;al., 2013</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">HIF-1&#x3b1;</td>
<td valign="top" align="center">Auxiliary the production of TNF</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B62">Otto et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="3" align="left">neutrophils</td>
<td valign="top" align="center">NETs</td>
<td valign="top" align="center">Kill <italic>CR-hvKP</italic> directly</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B41">Jin et&#xa0;al., 2020</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">IL-1&#x3b2;, IL-6, IL-17, IFN-&#x3b3;, CXCL2<break/>and TNF-&#x3b1;&#x2191;</td>
<td valign="top" align="center">Enhance ability to swallow and kill <italic>Kp</italic>
</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B53">Mancuso et&#xa0;al., 2022</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">CXCL5 and LTB<sub>4</sub>
</td>
<td valign="top" align="center">Restore the activity of neutrophils</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B7">Batra et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B18">Chen et&#xa0;al., 2016</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Innate lymphoid cells</td>
<td valign="top" align="center">STAT6 signal</td>
<td valign="top" align="center">IL-17A&#x2193;</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B11">Bloodworth et&#xa0;al., 2016</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">NK cells</td>
<td valign="top" align="center">Generate IFN-&#x3b3; and clear <italic>Kp</italic>
</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B36">Ivin et&#xa0;al., 2017</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="10" align="left">Immune molecules</td>
<td valign="top" align="left">TRIF</td>
<td valign="top" align="center">recruited into the TLR complex to activates NF-&#x3ba;B and type I IFN</td>
<td valign="top" align="center">Recruit neutrophils, activate MAPKs</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B15">Cai et&#xa0;al., 2009</xref>);</td>
</tr>
<tr>
<td valign="top" align="left">MyD88</td>
<td valign="top" align="center">recruited into the TLR complex to activate MAPK and NF-&#x3ba;B signal pathways</td>
<td valign="top" align="center">control bacterial growth at the infection site, thus minimizing bacterial transmission</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B40">Jeyaseelan et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B15">Cai et&#xa0;al., 2009</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="3" align="left">TLRs</td>
<td valign="top" align="center">TLR4 senses bacterial LPS</td>
<td valign="top" align="center">Against gram-negative bacteria</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B6">Baral et&#xa0;al., 2014</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">TLR2 and TLR4 improve the levels of TNF-&#x3b1;, MCP-1 and iNOS</td>
<td valign="top" align="center">indirectly eliminate <italic>Kp</italic>
</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B76">Schurr et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B39">Jeon et&#xa0;al., 2017</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">TLR9 triggers the<break/>proinflammatory cascade signal</td>
<td valign="top" align="center">Stimulate the production of TNF-&#x3b1; and IL-12</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B10">Bhan et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B82">Von Wulffen et&#xa0;al., 2007</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="5" align="left">NLRs</td>
<td valign="top" align="center">NLRP6 and NLRP12 can act as a negative regulator of the NF-&#x3ba;B and MAPK pathways</td>
<td valign="top" align="center">attenuate the intestinal inflammation</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B32">Ghimire et&#xa0;al., 2020</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">NLRP12-IL-17A-CXCL1 axis</td>
<td valign="top" align="center">Recruit neutrophils</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B14">Cai et&#xa0;al., 2016</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">IL-17 upregulate the expression<break/>of CCL2 and CCL7</td>
<td valign="top" align="center">Recruit neutrophils</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B88">Xiong et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B89">Xiong et&#xa0;al., 2016</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">NLRP12 reduce the production of TNF-&#x3b1; and IL-6</td>
<td valign="top" align="center">Attenuate the inflammation caused by <italic>Kp</italic>
</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B2">Allen et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B80">Tuladhar and Kanneganti, 2020</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">NLRC4 induce the production of IL-1&#x3b2; and IL-17A, activating MAPK and NF-&#x3ba;B signaling pathways</td>
<td valign="top" align="center">Recruit neutrophils</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B16">Cai et&#xa0;al., 2012</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="6" align="left">Adaptive immune response</td>
<td valign="top" rowspan="3" align="left">Cell-mediated immune response</td>
<td valign="top" rowspan="3" align="left"/>
<td valign="top" align="center">Th lymphocytes secrete IL-17 and IFN-&#x3b3;</td>
<td valign="top" align="center">plays a prominent role in the defense of <italic>Kp</italic>
</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B45">Lee et&#xa0;al., 2015</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">CD4 T<sub>RM</sub> cells</td>
<td valign="top" align="center">Release IFN-&#x3b3; or IL-4</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B3">Amezcua Vesely et&#xa0;al., 2019</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">lung T<sub>RM</sub> cells <italic>via</italic> fibroblast IL-17R signaling</td>
<td valign="top" align="center">provide immunity against <italic>Kp</italic>
</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B37">Iwanaga et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="3" align="left">Humoral immune response</td>
<td valign="top" rowspan="3" align="left">MAbs</td>
<td valign="top" align="center">CPS antigen</td>
<td valign="top" align="center">Strengthen biofilm inhibition, complement deposition and NETs</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B79">Soto et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B25">Diago-Navarro et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B26">Diago-Navarro et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B42">Kobayashi et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B56">Motley et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B5">Banerjee et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">O antigen of LPS</td>
<td valign="top" align="center">Promote the regulation and phagocytosis of macrophages</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B65">Pennini et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B9">Berry et&#xa0;al., 2022</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Vesicle antigen</td>
<td valign="top" align="center">Elicit EV reactive antibodies and produce IFN-&#x3b3; T cell response</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B45">Lee et&#xa0;al., 2015</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>It is put forward that the clearance and weakening of <italic>K. pneumoniae</italic> colonization by host mechanical barrier can be exploited by increasing the expression of <italic>mucin5b</italic> gene in respiratory mucus, maintaining normal renal urinary function and avoiding dysbiosis of the intestinal flora (<xref ref-type="bibr" rid="B73">Roy et&#xa0;al., 2014</xref>). It is confirmed that an essential aspect of <italic>Klebsiella</italic> infection biology is the thwarting of TLR-dependent activation of host defense responses controlled by NF-&#x3ba;B and MAPKs (<xref ref-type="bibr" rid="B40">Jeyaseelan et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B15">Cai et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B71">Regueiro et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B30">Frank et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B70">Ravi Kumar et&#xa0;al., 2018</xref>). We hypothesize that <italic>Klebsiella</italic> may target the cells responsible for producing immune cytokines and blockade the signaling pathways required for the production of the cytokines. Immune cells including DCs, macrophages and neutrophils are all capable of secreting cytokines and regulating inflammatory signal pathways. Therefore, enhancing inflammatory signaling pathways such as NF-&#x3ba;B and MAPKs by selectively inhibiting or enhancing the secretory function of immune cells is a direction of the future research (<xref ref-type="bibr" rid="B23">Deets and Vance, 2021</xref>). Further, drug development and clinical trials on antibodies that can effectively bind the antigenic epitopes of <italic>K. pneumoniae</italic> is also a powerful anti-infection tool (<xref ref-type="bibr" rid="B56">Motley et&#xa0;al., 2020</xref>).</p>
<p>When it comes to the host defense, anti-<italic>K. pneumoniae</italic> vaccines have to be mentioned. Anti-<italic>K. pneumoniae</italic> vaccine based on surface-exposed bacterial antigens is a promising alternative. CPS of <italic>K. pneumoniae</italic> has long been regarded as a vital virulence factor that promotes resistance to phagocytosis and serum bactericidal activity. Thus, CPS has been targeted previously for the development of therapeutics and vaccines (<xref ref-type="bibr" rid="B60">Opoku-Temeng et&#xa0;al., 2019</xref>). However, the high variability in capsular serotypes limits vaccine coverage, and glycoconjugate vaccines are manufactured using intricate chemical methodologies to covalently attach purified polysaccharides to carrier proteins, which is widely considered technically challenging (<xref ref-type="bibr" rid="B29">Feldman et&#xa0;al., 2019</xref>). Joy et&#xa0;al. developed a preclinical model of pneumonia in mice and found that non-capsular antigens may also elicit protective immunity (<xref ref-type="bibr" rid="B81">Twentyman et&#xa0;al., 2020</xref>). As a vital virulence factor, Outer Membrane Vesicles (OMV) could induce specific adaptive immune responses while displaying intrinsic adjuvant properties. However, the side effects of the OMV vaccine, the complexity of OMV composition, and the multiple antigens in variable concentrations hinder the mass production of OMV vaccines (<xref ref-type="bibr" rid="B54">Martora et&#xa0;al., 2019</xref>). In addition, the protective efficacy of ribosome-based vaccine formulations is controversial since many include surface protein contaminations, which may be significant contributors to the protective responses (<xref ref-type="bibr" rid="B68">Pregliasco et&#xa0;al., 2009</xref>). Remarkably recombinant outer membrane proteins (OMPs) are promising vaccine candidates against <italic>K. pneumoniae</italic>, alone or combined with other antigens. When administered as a carrier in combination with respiratory syncytial virus subgroup A (RSV-A), OMP could induce IgA, IgG1, and IgG2a production, which provided the protection against <italic>K. pneumoniae</italic> infection (<xref ref-type="bibr" rid="B47">Libon et&#xa0;al., 2002</xref>). Moreover, the O antigen on LPS is a highly immunogenic molecule and an essential virulence factor for <italic>K. pneumoniae</italic>. However, the high toxicity of LPS is the main limiting factor related to this type of vaccine. Thus, a delicate balance between immunogenicity and toxicity must be considered (<xref ref-type="bibr" rid="B22">Clarke et&#xa0;al., 2020</xref>). Although there are no vaccines available against <italic>K. pneumoniae</italic> infection in clinic, it is a great pleasure that K. pneumoniae vaccines are feasible and a promising strategy to prevent infections and reduce the antimicrobial resistance burden worldwide.</p>
<p>In summary, there is still a considerable gap in our understanding of the pathogenesis of <italic>K. pneumoniae</italic>. However, in-depth knowledge of the host-immune mechanism will facilitate understanding its pathogenesis and provide new ideas for future diagnosis and treatment of <italic>K. pneumoniae</italic> infection in the era of antibiotics.</p>
</sec>
<sec id="s5" sec-type="author-contributions">
<title>Author contributions</title>
<p>ZL reviewed all the literature, collected data, and drafted the manuscript. YW, YL, JZ and LY drafted partly and made important suggestions for the amendments. YS conceived the review and drafted partly. XL drafted partly and reviewed the manuscript. YZ and XY contributed substantially by giving insightful comments and suggestions during the creation of the manuscript. YS, XL and XY were responsible for funding. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s6" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by grants from the National Natural Science Foundation of China (No. 81671397, 81871956, 8210072867) and Health Commission of Hubei Province Foundation (WJ2019H528).</p>
</sec>
<sec id="s7" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s8" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Bander</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Nitert</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Mousa</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Naderpoor</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The gut microbiota and inflammation: An overview</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>17</volume>, <elocation-id>7618</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijerph17207618</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname> <given-names>I. C.</given-names>
</name>
<name>
<surname>Mcelvania-Tekippe</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Lich</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Arthur</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Sullivan</surname> <given-names>J. T.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Characterization of NLRP12 during the <italic>in vivo</italic> host immune response to <italic>Klebsiella pneumoniae</italic> and <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>PloS One</source> <volume>8</volume>, <elocation-id>e60842</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0060842</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amezcua Vesely</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Pallis</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Bielecki</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Low</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Harman</surname> <given-names>C. C. D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Effector T<sub>H</sub>17 cells give rise to long-lived T cells that are essential for an immediate response against bacterial infection</article-title>. <source>Cell</source> <volume>178</volume>, <fpage>176</fpage>&#x2013;<lpage>1188</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2019.07.032</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anas</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Claushuis</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Mohan</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Christoffels</surname> <given-names>V. M.</given-names>
</name>
<name>
<surname>Aidinis</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Florquin</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Epithelial myeloid-differentiation factor 88 is dispensable during <italic>Klebsiella pneumonia</italic>
</article-title>. <source>Am. J. Respir. Cell Mol. Biol.</source> <volume>56</volume>, <fpage>648</fpage>&#x2013;<lpage>656</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1165/rcmb.2016-0190OC</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Motley</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Diago-Navarro</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Fries</surname> <given-names>B. C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Serum antibody responses against carbapenem-resistant <italic>Klebsiella pneumoniae</italic> in infected patients</article-title>. <source>mSphere</source> <volume>6</volume>, <elocation-id>e01335-20</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mSphere.01335-20</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baral</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Batra</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zemans</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Downey</surname> <given-names>G. P.</given-names>
</name>
<name>
<surname>Jeyaseelan</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Divergent functions of toll-like receptors during bacterial lung infections</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>190</volume>, <fpage>722</fpage>&#x2013;<lpage>732</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201406-1101PP</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batra</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Balamayooran</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Jeyaseelan</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Intrapulmonary administration of leukotriene b (4) augments neutrophil accumulation and responses in the lung to <italic>Klebsiella</italic> infection in CXCL1 knockout mice</article-title>. <source>J. Immunol.</source> <volume>188</volume>, <fpage>3458</fpage>&#x2013;<lpage>3468</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1101985</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bengoechea</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Sa Pessoa</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>Klebsiella pneumoniae</italic> infection biology: living to counteract host defences</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>43</volume>, <fpage>123</fpage>&#x2013;<lpage>144</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/femsre/fuy043</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berry</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Rust</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Caceres</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Irving</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Bartholdson Scott</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Tabor</surname> <given-names>D. E.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Phenotypic whole-cell screening identifies a protective carbohydrate epitope on <italic>Klebsiella pneumoniae</italic>
</article-title>. <source>MAbs</source> <volume>14</volume>, <elocation-id>2006123</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19420862.2021.2006123</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhan</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Lukacs</surname> <given-names>N. W.</given-names>
</name>
<name>
<surname>Osterholzer</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Newstead</surname> <given-names>M. W.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>T. A.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>TLR9 is required for protective innate immunity in gram-negative bacterial pneumonia: role of dendritic cells</article-title>. <source>J. Immunol.</source> <volume>179</volume>, <fpage>3937</fpage>&#x2013;<lpage>3946</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.179.6.3937</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloodworth</surname> <given-names>M. H.</given-names>
</name>
<name>
<surname>Newcomb</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Dulek</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Stier</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Cephus</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>STAT6 signaling attenuates interleukin-17-producing &#x3b3;&#x3b4; T cells during acute <italic>Klebsiella pneumonia</italic>e infection</article-title>. <source>Infect. Immun.</source> <volume>84</volume>, <fpage>1548</fpage>&#x2013;<lpage>1555</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00646-15</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonilla</surname> <given-names>F. A.</given-names>
</name>
<name>
<surname>Oettgen</surname> <given-names>H. C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Adaptive immunity</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>125</volume>, <fpage>S33</fpage>&#x2013;<lpage>S40</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jaci.2009.09.017</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burnett</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Hochstedler</surname> <given-names>B. R.</given-names>
</name>
<name>
<surname>Weldon</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Wolfe</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Brubaker</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Recurrent urinary tract infection: Association of clinical profiles with urobiome composition in women</article-title>. <source>Neurourol. Urodyn.</source> <volume>40</volume>, <fpage>1479</fpage>&#x2013;<lpage>1489</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/nau.24707</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Batra</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Del Piero</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Jeyaseelan</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>NLRP12 modulates host defense through IL-17A-CXCL1 axis</article-title>. <source>Mucosal. Immunol.</source> <volume>9</volume>, <fpage>503</fpage>&#x2013;<lpage>514</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/mi.2015.80</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Batra</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wakamatsu</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Jeyaseelan</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary <italic>Klebsiella</italic> infection</article-title>. <source>J. Immunol.</source> <volume>183</volume>, <fpage>6629</fpage>&#x2013;<lpage>6638</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0901033</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Batra</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wakamatsu</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Pacher</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Jeyaseelan</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>NLRC4 inflammasome-mediated production of IL-1&#x3b2; modulates mucosal immunity in the lung against gram-negative bacterial infection</article-title>. <source>J. Immunol.</source> <volume>188</volume>, <fpage>5623</fpage>&#x2013;<lpage>5635</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1200195</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Paudel</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Ghimire</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Wakamatsu</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>NLRP6 modulates neutrophil homeostasis in bacterial pneumonia-derived sepsis</article-title>. <source>Mucosal. Immunol.</source> <volume>14</volume>, <fpage>574</fpage>&#x2013;<lpage>584</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41385-020-00357-4</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Eddens</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Trevejo-Nunez</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Way</surname> <given-names>E. E.</given-names>
</name>
<name>
<surname>Elsegeiny</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Ricks</surname> <given-names>D. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>IL-17 receptor signaling in the lung epithelium is required for mucosal chemokine gradients and pulmonary host defense against <italic>K. pneumoniae</italic>
</article-title>. <source>Cell Host Microbe</source> <volume>20</volume>, <fpage>596</fpage>&#x2013;<lpage>605</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2016.10.003</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Barletta</surname> <given-names>K. E.</given-names>
</name>
<name>
<surname>Burdick</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Mehrad</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors</article-title>. <source>Am. J. Physiol. Lung Cell Mol. Physiol.</source> <volume>305</volume>, <fpage>L702</fpage>&#x2013;<lpage>L711</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajplung.00194.2013</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chew</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>R. T. P.</given-names>
</name>
<name>
<surname>Teo</surname> <given-names>J. W. P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>In Singapore: Hypervirulent infections and the carbapenemase threat</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2017.00515</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choby</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Howard-Anderson</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>D. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Hypervirulent klebsiella pneumoniae-clinical and molecular perspectives</article-title>. <source>J. Intern. Med.</source> <volume>287</volume>, <fpage>283</fpage>&#x2013;<lpage>300</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/joim.13007</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname> <given-names>B. R.</given-names>
</name>
<name>
<surname>Ovchinnikova</surname> <given-names>O. G.</given-names>
</name>
<name>
<surname>Sweeney</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Kamski-Hennekam</surname> <given-names>E. R.</given-names>
</name>
<name>
<surname>Gitalis</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Mallette</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>A bifunctional O-antigen polymerase structure reveals a new glycosyltransferase family</article-title>. <source>Nat. Chem. Biol.</source> <volume>16</volume>, <fpage>450</fpage>&#x2013;<lpage>457</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41589-020-0494-0</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deets</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Vance</surname> <given-names>R. E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Inflammasomes and adaptive immune responses</article-title>. <source>Nat. Immunol.</source> <volume>22</volume>, <fpage>412</fpage>&#x2013;<lpage>422</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-021-00869-6</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Stoppelaar</surname> <given-names>S. F.</given-names>
</name>
<name>
<surname>Claushuis</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Jansen</surname> <given-names>M. P. B.</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Roelofs</surname> <given-names>J. J. T. H.</given-names>
</name>
<name>
<surname>Van&#x2019;t Veer</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>The role of platelet MyD88 in host response during gram-negative sepsis</article-title>. <source>J. Thromb. Haemost.</source> <volume>13</volume>, <fpage>1709</fpage>&#x2013;<lpage>1720</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jth.13048</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diago-Navarro</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Calatayud-Baselga</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Khairallah</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Mann</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Ulacia-Hernando</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Antibody-based immunotherapy to treat and prevent infection with <italic>hypervirulent klebsiella pneumoniae</italic>
</article-title>. <source>Clin. Vaccine Immunol.</source> <volume>24</volume>, <elocation-id>e00456-16</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/cvi.00456-16</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diago-Navarro</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Motley</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Ruiz-Per&#xe9;z</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Austin</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Seco</surname> <given-names>B. M. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Novel, broadly reactive anticapsular antibodies against <italic>carbapenem-resistant klebsiella pneumoniae</italic> protect from infection</article-title>. <source>mBio</source> <volume>9</volume>, <elocation-id>e00091-18</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00091-18</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diekema</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Hsueh</surname> <given-names>P.-R.</given-names>
</name>
<name>
<surname>Mendes</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Pfaller</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Rolston</surname> <given-names>K. V.</given-names>
</name>
<name>
<surname>Sader</surname> <given-names>H. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>63</volume>, <elocation-id>e00355-19</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.00355-19</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elinav</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Strowig</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kau</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Henao-Mejia</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Thaiss</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Booth</surname> <given-names>C. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis</article-title>. <source>Cell</source> <volume>145</volume>, <fpage>745</fpage>&#x2013;<lpage>757</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2011.04.022</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feldman</surname> <given-names>M. F.</given-names>
</name>
<name>
<surname>Mayer Bridwell</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>N. E.</given-names>
</name>
<name>
<surname>Vinogradov</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Mckee</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Chavez</surname> <given-names>S. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>A promising bioconjugate vaccine against <italic>hypervirulent klebsiella pneumoniae</italic>
</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>116</volume>, <fpage>18655</fpage>&#x2013;<lpage>18663</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1907833116</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frank</surname> <given-names>C. G.</given-names>
</name>
<name>
<surname>Reguerio</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Rother</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Moranta</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Maeurer</surname> <given-names>A. P.</given-names>
</name>
<name>
<surname>Garmendia</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>
<italic>Klebsiella pneumoniae</italic> targets an EGF receptor-dependent pathway to subvert inflammation</article-title>. <source>Cell Microbiol.</source> <volume>15</volume>, <fpage>1212</fpage>&#x2013;<lpage>1233</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cmi.12110</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galv&#xe3;o</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Tavares</surname> <given-names>L. P.</given-names>
</name>
<name>
<surname>Corr&#xea;a</surname> <given-names>R. O.</given-names>
</name>
<name>
<surname>Fachi</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Rocha</surname> <given-names>V. M.</given-names>
</name>
<name>
<surname>Rungue</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>The metabolic sensor GPR43 receptor plays a role in the control of <italic>Klebsiella pneumoniae</italic> infection in the lung</article-title>. <source>Front. Immunol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.00142</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghimire</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Paudel</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Jeyaseelan</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The NLRP6 inflammasome in health and disease</article-title>. <source>Mucosal. Immunol.</source> <volume>13</volume>, <fpage>388</fpage>&#x2013;<lpage>398</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41385-020-0256-z</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hackstein</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kranz</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Lippitsch</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Wachtendorf</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kershaw</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Gruber</surname> <given-names>A. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Modulation of respiratory dendritic cells during <italic>Klebsiella pneumonia</italic> infection</article-title>. <source>Respir. Res.</source> <volume>14</volume>, <elocation-id>91</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1465-9921-14-91</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hackstein</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wachtendorf</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kranz</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Lohmeyer</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Bein</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Baal</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Heterogeneity of respiratory dendritic cell subsets and lymphocyte populations in inbred mouse strains</article-title>. <source>Respir. Res.</source> <volume>13</volume>, <elocation-id>94</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1465-9921-13-94</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holt</surname> <given-names>K. E.</given-names>
</name>
<name>
<surname>Wertheim</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zadoks</surname> <given-names>R. N.</given-names>
</name>
<name>
<surname>Baker</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Whitehouse</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Dance</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in <italic>Klebsiella pneumoniae</italic>, an urgent threat to public health</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>112</volume>, <fpage>e3574</fpage>&#x2013;<lpage>e3581</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1501049112</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Dumigan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>De Vasconcelos</surname> <given-names>F. N.</given-names>
</name>
<name>
<surname>Ebner</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Borroni</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kavirayani</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Natural killer cell-intrinsic type I IFN signaling controls <italic>Klebsiella pneumoniae</italic> growth during lung infection</article-title>. <source>PloS Pathog.</source> <volume>13</volume>, <elocation-id>e1006696</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1006696</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwanaga</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Wanek</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Vaccine-driven lung T<sub>RM</sub> cells provide immunity against <italic>Klebsiella via</italic> fibroblast IL-17R signaling</article-title>. <source>Sci. Immunol.</source> <volume>6</volume>, <elocation-id>eabf1198</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciimmunol.abf1198</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jagnow</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Clegg</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>
<italic>Klebsiella pneumoniae</italic> MrkD-mediated biofilm formation on extracellular matrix- and collagen-coated surfaces</article-title>. <source>Microbiol. (Reading)</source> <volume>149</volume>, <fpage>2397</fpage>&#x2013;<lpage>2405</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mic.0.26434-0</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeon</surname> <given-names>H.-Y.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>J.-H.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>J.-I.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>J.-Y.</given-names>
</name>
<name>
<surname>Seo</surname> <given-names>S.-M.</given-names>
</name>
<name>
<surname>Ham</surname> <given-names>S.-H.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Cooperative interactions between toll-like receptor 2 and toll-like receptor 4 in murine <italic>Klebsiella pneumoniae</italic> infections</article-title>. <source>J. Microbiol. Biotechnol.</source> <volume>27</volume>, <fpage>1529</fpage>&#x2013;<lpage>1538</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4014/jmb.1704.04039</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeyaseelan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Young</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Yamamoto</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Arndt</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Akira</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kolls</surname> <given-names>J. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against <italic>Klebsiella pneumoniae</italic> but not <italic>Pseudomonas aeruginosa.</italic> J</article-title>. <source>Immunol</source> <volume>177</volume>, <fpage>538</fpage>&#x2013;<lpage>547</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.177.1.538</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Jing</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Neutrophil extracellular traps (NETs)-mediated killing of <italic>carbapenem-resistant hypervirulent</italic> (<italic>CR-hvKP</italic>) are impaired in patients with diabetes mellitus</article-title>. <source>Virulence</source> <volume>11</volume>, <fpage>1122</fpage>&#x2013;<lpage>1130</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2020.1809325</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname> <given-names>S. D.</given-names>
</name>
<name>
<surname>Porter</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Freedman</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Pandey</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Kreiswirth</surname> <given-names>B. N.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Antibody-mediated killing of carbapenem-resistant ST258 <italic>Klebsiella pneumoniae</italic> by human neutrophils</article-title>. <source>mBio</source> <volume>9</volume>, <elocation-id>e00297-18</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00297-18</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovach</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Singer</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Martinez-Colon</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Newstead</surname> <given-names>M. W.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Mancuso</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>IL-36&#x3b3; is a crucial proximal component of protective type-1-mediated lung mucosal immunity in gram-positive and -negative bacterial pneumonia</article-title>. <source>Mucosal. Immunol.</source> <volume>10</volume>, <fpage>1320</fpage>&#x2013;<lpage>1334</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/mi.2016.130</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovach</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Singer</surname> <given-names>B. H.</given-names>
</name>
<name>
<surname>Newstead</surname> <given-names>M. W.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>T. A.</given-names>
</name>
<name>
<surname>White</surname> <given-names>E. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>IL-36&#x3b3; is secreted in microparticles and exosomes by lung macrophages in response to bacteria and bacterial components</article-title>. <source>J. Leukoc. Biol.</source> <volume>100</volume>, <fpage>413</fpage>&#x2013;<lpage>421</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.4A0315-087R</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>W. H.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>H. I.</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>S. W.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>K. S.</given-names>
</name>
<name>
<surname>Gho</surname> <given-names>Y. S.</given-names>
</name>
<name>
<surname>Jeon</surname> <given-names>S. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Vaccination with <italic>Klebsiella pneumoniae</italic>-derived extracellular vesicles protects against bacteria-induced lethality <italic>via</italic> both humoral and cellular immunity</article-title>. <source>Exp. Mol. Med.</source> <volume>47</volume>, <fpage>e183</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/emm.2015.59</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>I. M.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>T.-Y.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>F.-L.</given-names>
</name>
<name>
<surname>Johansson</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>C.-R.</given-names>
</name>
<name>
<surname>Hsieh</surname> <given-names>P.-F.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>A hexasaccharide from capsular polysaccharide of <italic>carbapenem-resistant klebsiella pneumoniae KN2</italic> is a ligand of toll-like receptor 4</article-title>. <source>Carbohydr. Polym.</source> <volume>278</volume>, <elocation-id>118944</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.carbpol.2021.118944</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Libon</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Haeuw</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Crouzet</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Mugnier</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Bonnefoy</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Beck</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2002</year>). <article-title>
<italic>Streptococcus pneumoniae</italic> polysaccharides conjugated to the outer membrane protein a from <italic>Klebsiella pneumoniae</italic> elicit protective antibodies</article-title>. <source>Vaccine</source> <volume>20</volume>, <fpage>2174</fpage>&#x2013;<lpage>2180</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0264-410x(02)00149-4</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>W. Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z. J.</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>L. C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>
<italic>Klebsiella pneumoniae</italic> MrkD adhesin-mediated immunity to respiratory infection and mapping the antigenic epitope by phage display library</article-title>. <source>Microb. Pathog.</source> <volume>46</volume>, <fpage>144</fpage>&#x2013;<lpage>149</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2008.11.006</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Development of drug-resistant vaccine <italic>via</italic> novel vesicle production technology</article-title>. <source>ACS Appl. Mater. Interfaces</source> <volume>13</volume>, <fpage>32703</fpage>&#x2013;<lpage>32715</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acsami.1c06701</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Molecular pathogenesis of <italic>Klebsiella pneumoniae</italic>
</article-title>. <source>Future Microbiol.</source> <volume>9</volume>, <fpage>1071</fpage>&#x2013;<lpage>1081</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2217/fmb.14.48</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mackel</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Morffy Smith</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wasbotten</surname> <given-names>R. K.</given-names>
</name>
<name>
<surname>Twentyman</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Rosen</surname> <given-names>D. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Classical and &#x3b3;&#x3b4; T cells are each independently sufficient to establish protection against a classical strain of</article-title>. <source>Klebsiella pneumoniae. Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.974175</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mamantopoulos</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ronchi</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Van Hauwermeiren</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Vieira-Silva</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yilmaz</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Martens</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>
<italic>Nlrp6-</italic> and ASC-dependent inflammasomes do not shape the commensal gut microbiota composition</article-title>. <source>Immunity</source> <volume>47</volume>, <fpage>339</fpage>&#x2013;<lpage>348.e334</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2017.07.011</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mancuso</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Curtis</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Weitzel</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Griffin</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Bouchard</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Freeman</surname> <given-names>C. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Diet-induced obesity in mice impairs host defense against pneumonia <italic>in vivo</italic> and glucose transport and bactericidal functions in neutrophils <italic>in vitro</italic>
</article-title>. <source>Am. J. Physiol. Lung Cell Mol. Physiol.</source> <volume>322</volume>, <fpage>L116</fpage>&#x2013;<lpage>L128</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajplung.00008.2021</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martora</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Pinto</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Folliero</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Cammarota</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Dell'annunziata</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Squillaci</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Isolation, characterization and analysis of pro-inflammatory potential of <italic>Klebsiella pneumoniae</italic> outer membrane vesicles</article-title>. <source>Microb. Pathog.</source> <volume>136</volume>, <elocation-id>103719</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2019.103719</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maunders</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Ganio</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hayes</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Neville</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Davies</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Strugnell</surname> <given-names>R. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>The role of ZntA in <italic>Klebsiella pneumoniae</italic> zinc homeostasis</article-title>. <source>Microbiol. Spectr.</source> <volume>10</volume>, <elocation-id>e0177321</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/spectrum.01773-21</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Motley</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Diago-Navarro</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Banerjee</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Inzerillo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Fries</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>Fries</surname> <given-names>B. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The role of IgG subclass in antibody-mediated protection against <italic>carbapenem-resistant klebsiella pneumoniae</italic>
</article-title>. <source>mBio</source> <volume>11</volume>, <elocation-id>e02059-20</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.02059-20</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myers</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>J. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Exploring the NK cell platform for cancer immunotherapy</article-title>. <source>Nat. Rev. Clin. Oncol.</source> <volume>18</volume>, <fpage>85</fpage>&#x2013;<lpage>100</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41571-020-0426-7</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Na</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Bo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G. X.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>X. F.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Studies affecting the role of <italic>Klebsiella pneumoniae</italic> in adherence to epithelial cells</article-title>. <source>Sichuan J. Physiol. Sci.</source> <volume>36</volume>, <fpage>3</fpage>&#x2013;<lpage>6</lpage>.</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;neill</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Golenbock</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Bowie</surname> <given-names>A. G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The history of toll-like receptors-redefining innate immunity</article-title>. <source>Nat. Rev. Immunol.</source> <volume>13</volume>, <fpage>453</fpage>&#x2013;<lpage>460</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3446</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opoku-Temeng</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>S. D.</given-names>
</name>
<name>
<surname>Deleo</surname> <given-names>F. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>Klebsiella pneumoniae</italic> capsule polysaccharide as a target for therapeutics and vaccines</article-title>. <source>Comput. Struct. Biotechnol. J.</source> <volume>17</volume>, <fpage>1360</fpage>&#x2013;<lpage>1366</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.csbj.2019.09.011</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opoku-Temeng</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Malachowa</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>S. D.</given-names>
</name>
<name>
<surname>Deleo</surname> <given-names>F. R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Innate host defense against <italic>Klebsiella pneumoniae</italic> and the outlook for development of immunotherapies</article-title>. <source>J. Innate Immun.</source> <volume>14</volume>, <fpage>167</fpage>&#x2013;<lpage>181</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000518679</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otto</surname> <given-names>N. A.</given-names>
</name>
<name>
<surname>Pereverzeva</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Leopold</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Ramirez-Moral</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Roelofs</surname> <given-names>J. J. T. H.</given-names>
</name>
<name>
<surname>Van Heijst</surname> <given-names>J. W. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Hypoxia-inducible factor-1 in macrophages, but not in neutrophils, is important for host defense during-induced pneumosepsis</article-title>. <source>Mediators. Inflamm.</source> <volume>2021</volume>, <elocation-id>9958281</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2021/9958281</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paczosa</surname> <given-names>M. K.</given-names>
</name>
<name>
<surname>Mecsas</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>
<italic>Klebsiella pneumoniae</italic>: Going on the offense with a strong defense</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>80</volume>, <fpage>629</fpage>&#x2013;<lpage>661</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MMBR.00078-15</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pallmer</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Oxenius</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Recognition and regulation of T cells by NK cells</article-title>. <source>Front. Immunol.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2016.00251</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pennini</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>De Marco</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Pelletier</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bonnell</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Cvitkovic</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Beltramello</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant <italic>Klebsiella pneumoniae</italic>
</article-title>. <source>Nat. Commun.</source> <volume>8</volume>, <fpage>1991</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-017-02223-7</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pichavant</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Delneste</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Jeannin</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Fourneau</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Brichet</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gosset</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Outer membrane protein a from <italic>Klebsiella pneumoniae</italic> activates bronchial epithelial cells: implication in neutrophil recruitment</article-title>. <source>J. Immuno.</source> <volume>171</volume>, <fpage>6697</fpage>&#x2013;<lpage>6705</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.171.12.6697</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plantinga</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Guilliams</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Vanheerswynghels</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Deswarte</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Branco-Madeira</surname>
</name>
<name>
<surname>Toussaint</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen</article-title>. <source>Immunity</source> <volume>38</volume>, <fpage>322</fpage>&#x2013;<lpage>335</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2012.10.016</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pregliasco</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Terracciano</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Marcassa</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zava</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Anselmi</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Rationale for the clinical use of a ribosome-component immune modulator</article-title>. <source>Allergy Asthma Proc.</source> <volume>30 Suppl 1</volume>, <fpage>S5</fpage>&#x2013;<lpage>12</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2500/aap.2009.30.3249</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramirez-Moral</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Blok</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Bernink</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Garcia-Laorden</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Florquin</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Boon</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Interleukin-33 improves local immunity during gram-negative pneumonia by a combined effect on neutrophils and inflammatory monocytes</article-title>. <source>J. Pathol.</source> <volume>253</volume>, <fpage>374</fpage>&#x2013;<lpage>383</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/path.5601</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravi Kumar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Paudel</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ghimire</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Bergeron</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zemans</surname> <given-names>R. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Emerging roles of inflammasomes in acute pneumonia</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>197</volume>, <fpage>160</fpage>&#x2013;<lpage>171</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201707-1391PP</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Regueiro</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Moranta</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Frank</surname> <given-names>C. G.</given-names>
</name>
<name>
<surname>Larrarte</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Margareto</surname> <given-names>J.</given-names>
</name>
<name>
<surname>March</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>
<italic>Klebsiella pneumoniae</italic> subverts the activation of inflammatory responses in a NOD1-dependent manner</article-title>. <source>Cell Microbiol.</source> <volume>13</volume>, <fpage>135</fpage>&#x2013;<lpage>153</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1462-5822.2010.01526</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Medina</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Barrios-Camacho</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Duran-Bedolla</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Garza-Ramos</surname> <given-names>U.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>Klebsiella variicola</italic>: an emerging pathogen in humans</article-title>. <source>Emerg. Microbes Infect.</source> <volume>8</volume>, <fpage>973</fpage>&#x2013;<lpage>988</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/22221751.2019.1634981</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Livraghi-Butrico</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Fletcher</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Mcelwee</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Boerner</surname> <given-names>R. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>
<italic>Muc5b</italic> is required for airway defence</article-title>. <source>Nature</source> <volume>505</volume>, <fpage>412</fpage>&#x2013;<lpage>416</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature12807</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russo</surname> <given-names>T. A.</given-names>
</name>
<name>
<surname>Marr</surname> <given-names>C. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Hypervirulent klebsiella pneumoniae</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>32</volume>, <elocation-id>e00001-19</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00001-19</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saharman</surname> <given-names>Y. R.</given-names>
</name>
<name>
<surname>Karuniawati</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sedono</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Aditianingsih</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Goessens</surname> <given-names>W. H. F.</given-names>
</name>
<name>
<surname>Klaassen</surname> <given-names>C. H. W.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Clinical impact of endemic NDM-producing <italic>Klebsiella pneumoniae</italic> in intensive care units of the national referral hospital in Jakarta, Indonesia</article-title>. <source>Antimicrob. Resist. Infect. Control</source> <volume>9</volume>, <fpage>61</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13756-020-00716-7</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schurr</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Young</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Byrne</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Steele</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Shellito</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Shellito</surname> <given-names>J. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by gram-negative bacteria</article-title>. <source>Infect. Immun.</source> <volume>73</volume>, <fpage>532</fpage>&#x2013;<lpage>545</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.73.1.532-545.2005</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sequeira</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Mcdonald</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Marchesi</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Clarke</surname> <given-names>T. B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Commensal bacteroidetes protect against <italic>Klebsiella pneumoniae</italic> colonization and transmission through IL-36 signalling</article-title>. <source>Nat. Microbiol.</source> <volume>5</volume>, <fpage>304</fpage>&#x2013;<lpage>313</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-019-0640-1</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Niu</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Interaction between the gut microbiome and mucosal immune system</article-title>. <source>Mil. Med. Res.</source> <volume>4</volume>, <fpage>14</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40779-017-0122-9</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soto</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Marchi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Beierschmitt</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kearney</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Francis</surname> <given-names>S.</given-names>
</name>
<name>
<surname>VanNess</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Interaction of non-human primate complement and antibodies with <italic>hypermucoviscous klebsiella pneumoniae</italic>
</article-title>. <source>Vet. Res.</source> <volume>47</volume>, <fpage>40</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13567-016-0325-1</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuladhar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kanneganti</surname> <given-names>T.-D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>NLRP12 in innate immunity and inflammation</article-title>. <source>Mol. Aspects Med.</source> <volume>76</volume>, <elocation-id>100887</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mam.2020.100887</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Twentyman</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Morffy Smith</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Nims</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Dahler</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Rosen</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Rosen</surname> <given-names>D.A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>A murine model demonstrates capsule-independent adaptive immune protection in survivors of <italic>Klebsiella pneumoniae</italic> respiratory tract infection</article-title>. <source>Dis. Model. Mech.</source> <volume>13</volume>, <elocation-id>dmm043240</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/dmm.043240</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Von Wulffen</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Steinmueller</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Herold</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Marsh</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Bulau</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Seeger</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Lung dendritic cells elicited by fms-like tyrosine 3-kinase ligand amplify the lung inflammatory response to lipopolysaccharide</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>176</volume>, <fpage>892</fpage>&#x2013;<lpage>901</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1465-9921-14-91</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vornhagen</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Bassis</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hein</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Mason</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Bergman</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>A plasmid locus associated with <italic>Klebsiella</italic> clinical infections encodes a microbiome-dependent gut fitness factor</article-title>. <source>PloS Pathog.</source> <volume>17</volume>, <elocation-id>e1009537</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1009537</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Chao</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The characteristic of virulence, biofilm and antibiotic resistance of <italic>Klebsiella pneumoniae</italic>
</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>17</volume>, <elocation-id>6278</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijerph17176278</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wasfi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Abdellatif</surname> <given-names>G. R.</given-names>
</name>
<name>
<surname>Elshishtawy</surname> <given-names>H. M.</given-names>
</name>
<name>
<surname>Ashour</surname> <given-names>H. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>First-time characterization of viable but non-culturable proteus mirabilis: Induction and resuscitation</article-title>. <source>J. Cell Mol. Med.</source> <volume>24</volume>, <fpage>2791</fpage>&#x2013;<lpage>2801</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jcmm.15031</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolff</surname> <given-names>N. S.</given-names>
</name>
<name>
<surname>Jacobs</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Wiersinga</surname> <given-names>W. J.</given-names>
</name>
<name>
<surname>Hugenholtz</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Pulmonary and intestinal microbiota dynamics during gram-negative pneumonia-derived sepsis</article-title>. <source>Intensive Care Med. Exp.</source> <volume>9</volume>, <elocation-id>35</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40635-021-00398-4</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Alterations in the gut microbiome and cecal metabolome during <italic>Klebsiella pneumoniae</italic>-induced pneumosepsis</article-title>. <source>Front. Immunol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01331</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Carter</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Leiner</surname> <given-names>I. M.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Y.-W.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Kreiswirth</surname> <given-names>B. N.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Distinct contributions of neutrophils and CCR2<sup>+</sup> monocytes to pulmonary clearance of different <italic>Klebsiella pneumoniae</italic> strains</article-title>. <source>Infect. Immun.</source> <volume>83</volume>, <fpage>3418</fpage>&#x2013;<lpage>3427</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00678-15</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Keith</surname> <given-names>J. W.</given-names>
</name>
<name>
<surname>Samilo</surname> <given-names>D. W.</given-names>
</name>
<name>
<surname>Carter</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Leiner</surname> <given-names>I. M.</given-names>
</name>
<name>
<surname>Pamer</surname> <given-names>E. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Innate Lymphocyte/Ly6C(hi) monocyte crosstalk promotes <italic>Klebsiella pneumoniae</italic> clearance</article-title>. <source>Cell</source> <volume>165</volume>, <fpage>679</fpage>&#x2013;<lpage>689</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2016.03.017</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>I. D.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H. H.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Wynn</surname> <given-names>T. A.</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>M. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Conventional NK cells can produce IL-22 and promote host defense in <italic>Klebsiella pneumoniae</italic> pneumonia</article-title>. <source>J. Immunol.</source> <volume>192</volume>, <fpage>1778</fpage>&#x2013;<lpage>1786</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1300039</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Small airway epithelial cell injury induced by <italic>Klebsiella pneumoniae</italic> in rats and its relationship with intrapulmonary alpha tumor necrosis factor</article-title>. <source>Chin. J. Biochem. Drugs</source> <volume>1</volume>, <fpage>12</fpage>&#x2013;<lpage>14</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3969/j.issn.1005-1678.2005.01.0012-03</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Li.</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Denstedt</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Cadieux</surname> <given-names>P. A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The influence of urinary pH on antibiotic efficacy against bacterial uropathogens</article-title>. <source>Urology</source> <volume>84</volume>, <fpage>731.e731</fpage>&#x2013;<lpage>737</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.urology.2014.04.048</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Effect of airborne PM2.5 exposure on the inflammatory response to <italic>Klebsiella pneumoniae</italic> in rat lungs</article-title>. <source>Basic Med. Clin.</source> <volume>34</volume>, <fpage>1110</fpage>&#x2013;<lpage>1112</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.16352/j.issn.1001-6325.2014.08.017</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Gut microbiota contributes to host defense against <italic>Klebsiella pneumoniae</italic>-induced liver abscess</article-title>. <source>J. Inflamm. Res.</source> <volume>14</volume>, <fpage>5215</fpage>&#x2013;<lpage>5225</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/jir.S334581</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>